comparemela.com

Latest Breaking News On - ப்ராடக்ட்ஸ் நிறுவனம் - Page 17 : comparemela.com

Global Recreational Boats Market Report 2021-2027: Opportunities in Innovation in Boat Engines and Integration of IoT & Sensor-Based Technologies

Share this article Share this article ResearchAndMarkets.com s offering. The recreational boats market is expected to grow at a CAGR of 7.8% from 2020 to 2027 to reach $54.9 billion by 2027 The growth of this market is mainly attributed to the booming tourism industry, growing economic development, growing participation in boating activities, innovation in boat engines, and increasing disposable income. These trends and the rising adoption of boating in Asian countries, including China, Japan, and Australia, offer manufacturers with new markets to capture over the forecast timespan. However, cyber-attacks & the intangible threat to the cruise industry, and high capital investment are expected to hinder the growth of this market to some extent.

Bangladesh approves China s Sinopharm coronavirus vaccine

Bangladesh approves China s Sinopharm coronavirus vaccine Reuters 7 hrs ago By Ruma Paul DHAKA, April 29 (Reuters) - Bangladesh s drug regulator said on Thursday it had approved the emergency use of a vaccine developed by an affiliate of China’s Sinopharm, as it scrambles to find alternative sources for COVID-19 inoculations after supplies from India faltered. Bangladesh s vaccination drive suffered after its bigger neighbor halted exports of the AstraZeneca shot in response to a record surge in domestic infections. Hopefully, 500,000 doses of the Sinopharm vaccine will arrive in Bangladesh within two weeks, Mahbubur Rahman, head of the Directorate General of Drug Administration, told reporters.

Bangladesh approves China s Sinopharm vaccine

Bangladesh approves China s Sinopharm coronavirus vaccine Reuters 4/29/2021 By Ruma Paul DHAKA, April 29 (Reuters) - Bangladesh s drug regulator said on Thursday it had approved the emergency use of a vaccine developed by an affiliate of China’s Sinopharm, as it scrambles to find alternative sources for COVID-19 inoculations after supplies from India faltered. Bangladesh s vaccination drive suffered after its bigger neighbor halted exports of the AstraZeneca shot in response to a record surge in domestic infections. Hopefully, 500,000 doses of the Sinopharm vaccine will arrive in Bangladesh within two weeks, Mahbubur Rahman, head of the Directorate General of Drug Administration, told reporters.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.